来自Dendrobium的皮克罗托克桑类型的基类化合物可以改善胰岛素耐药性,并增加葡萄糖刺激的胰岛素分泌
Han-Fen Li1, Hui-Yan Shao2, Ni Huang1
1Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, Yunnan, China; University of Chinese Academy of Sciences, Beijing 100049, China.
Bioorganic chemistry
|December 20, 2024
概括
来自Dendrobium wardianum的新甲烯酸显示出显著的抗糖尿病潜力. 几种化合物改善了胰岛素抵抗和胰岛素分泌,其中一种化合物通过GLUT-4和AKT通路起作用.
科学领域:
- 自然产品 化学 化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 丹德罗 (Dendrobium wardianum) 是一种生物活性化合物的来源.
- 皮克罗托克桑类型的甲类化合物代表了一类具有潜在治疗应用的天然产品.
研究的目的:
- 从Dendrobium wardianum中分离和表征新的皮克罗托克桑类型的石.
- 评估这些化合物和相关类型的低血糖和抗糖尿病活性.
- 阐明这些类的作用机制和结构-活性关系 (SARs).
主要方法:
- 使用染色学技术分离和净化类.
- 使用全面的光谱分析进行结构阐明,包括1D和2D核磁共振 (NMR) 和单晶X射线衍射.
- 在体外评估抗糖尿病活性,包括改善胰岛素抵抗,增强胰岛素分泌和作用机制研究 (例如GLUT-4表达,AKT通路分析).
主要成果:
- 已经分离出12种皮克罗托克桑类型的化物,包括4种新化合物 (K-N型登德罗瓦丁) 和2种新天然产物 (O型和P型登德罗瓦丁).
- 化合物树突丁K具有一种罕见的10,11-γ-乳环.
- 十二种化合物显著改善了胰岛素抵抗.
- 化合物6通过上调GLUT-4表达来增强胰岛素抵抗,可能通过与AKT相关的途径,其效果与甲胺相似.
- 化合物4-6和13-15,17显著增加了β-TC-6细胞的胰岛素分泌.
结论:
- 丹德罗比 (Dendrobium wardianum) 产生的新型皮克罗托克桑类型的基类化合物具有有前途的抗糖尿病特性.
- 几个分离的化合物有效地改善了胰岛素抵抗和胰岛素分泌,突出了它们对糖尿病的治疗潜力.
- 这项研究为皮克罗托克桑类型的甲类药物提供了第一个SAR分析,为未来的药物开发提供了洞察力.
相关概念视频
Glucagon-like Receptor Agonists
297
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
297
Dipeptidyl Peptidase 4 Inhibitors
167
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
167
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones
168
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
168
Insulin Secretory Vesicles
4.8K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K
Oral Hypoglycemic Agents: Glinides
136
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
136


